Results
|
81.
|
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. [electronic resource] by
- Carducci, M A
- Gilbert, J
- Bowling, M K
- Noe, D
- Eisenberger, M A
- Sinibaldi, V
- Zabelina, Y
- Chen, T L
- Grochow, L B
- Donehower, R C
Producer: 20011205
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7
Availability: No items available.
|
|
82.
|
|
|
83.
|
Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements. [electronic resource] by
- Hooker, A C
- Ten Tije, A J
- Carducci, M A
- Weber, J
- Garrett-Mayer, E
- Gelderblom, H
- McGuire, W P
- Verweij, J
- Karlsson, M O
- Baker, S D
Producer: 20080707
In:
Clinical pharmacology and therapeutics vol. 84
Availability: No items available.
|
|
84.
|
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. [electronic resource] by
- Roberts, W W
- Bergstralh, E J
- Blute, M L
- Slezak, J M
- Carducci, M
- Han, M
- Epstein, J I
- Eisenberger, M A
- Walsh, P C
- Partin, A W
Producer: 20020304
In:
Urology vol. 57
Availability: No items available.
|
|
85.
|
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer. [electronic resource] by
- Armstrong, A J
- Häggman, M
- Stadler, W M
- Gingrich, J R
- Assikis, V
- Polikoff, J
- Damber, J E
- Belkoff, L
- Nordle, Ö
- Forsberg, G
- Carducci, M A
- Pili, R
Producer: 20140826
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
86.
|
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer. [electronic resource] by
- Morris, M J
- Eisenberger, M A
- Pili, R
- Denmeade, S R
- Rathkopf, D
- Slovin, S F
- Farrelly, J
- Chudow, J J
- Vincent, M
- Scher, H I
- Carducci, M A
Producer: 20130329
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
87.
|
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors. [electronic resource] by
- Heath, E I
- O'Reilly, S
- Humphrey, R
- Sundaresan, P
- Donehower, R C
- Sartorius, S
- Kennedy, M J
- Armstrong, D K
- Carducci, M A
- Sorensen, J M
- Kumor, K
- Kennedy, S
- Grochow, L B
Producer: 20011207
In:
Cancer chemotherapy and pharmacology vol. 48
Availability: No items available.
|
|
88.
|
Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile. [electronic resource] by
- Wolff, Antonio C
- Donehower, Ross C
- Carducci, M Katherine
- Carducci, Michael A
- Brahmer, Julie R
- Zabelina, Yelena
- Bradley, Matthews O
- Anthony, Forrest H
- Swindell, Charles S
- Witman, Philip A
- Webb, Nigel L
- Baker, Sharyn D
Producer: 20040528
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9
Availability: No items available.
|
|
89.
|
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. [electronic resource] by
- Pratz, K W
- Cho, E
- Levis, M J
- Karp, J E
- Gore, S D
- McDevitt, M
- Stine, A
- Zhao, M
- Baker, S D
- Carducci, M A
- Wright, J J
- Rudek, M A
- Smith, B D
Producer: 20100914
In:
Leukemia vol. 24
Availability: No items available.
|
|
90.
|
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. [electronic resource] by
- Paller, C J
- Ye, X
- Wozniak, P J
- Gillespie, B K
- Sieber, P R
- Greengold, R H
- Stockton, B R
- Hertzman, B L
- Efros, M D
- Roper, R P
- Liker, H R
- Carducci, M A
Producer: 20130809
In:
Prostate cancer and prostatic diseases vol. 16
Availability: No items available.
|
|
91.
|
Pharmacogenetic pathway analysis of docetaxel elimination. [electronic resource] by
- Baker, S D
- Verweij, J
- Cusatis, G A
- van Schaik, R H
- Marsh, S
- Orwick, S J
- Franke, R M
- Hu, S
- Schuetz, E G
- Lamba, V
- Messersmith, W A
- Wolff, A C
- Carducci, M A
- Sparreboom, A
Producer: 20090210
In:
Clinical pharmacology and therapeutics vol. 85
Availability: No items available.
|
|
92.
|
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. [electronic resource] by
- Lara, P N
- Plets, M
- Tangen, C
- Gertz, E
- Vogelzang, N J
- Hussain, M
- Twardowski, P W
- Garzotto, M G
- Monk, J P
- Carducci, M
- Goldkorn, A
- Mack, P C
- Thompson, I
- Van Loan, M
- Quinn, D I
Publication details: Cancer treatment and research communications 2018
In:
Cancer treatment and research communications vol. 16
Availability: No items available.
|
|
93.
|
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. [electronic resource] by
- DeWeese, T L
- van der Poel, H
- Li, S
- Mikhak, B
- Drew, R
- Goemann, M
- Hamper, U
- DeJong, R
- Detorie, N
- Rodriguez, R
- Haulk, T
- DeMarzo, A M
- Piantadosi, S
- Yu, D C
- Chen, Y
- Henderson, D R
- Carducci, M A
- Nelson, W G
- Simons, J W
Producer: 20011204
In:
Cancer research vol. 61
Availability: No items available.
|
|
94.
|
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. [electronic resource] by
- Armstrong, A J
- Halabi, S
- Healy, P
- Lee, W R
- Koontz, B F
- Moul, J W
- Mundy, K
- Creel, P
- Wood, S
- Davis, K
- Carducci, M A
- Stein, M
- Hobbs, C
- Reimer, B
- Nguyen, M
- Anand, M
- Bratt, L
- Kim, S
- Tran, P T
- George, D J
Producer: 20161027
In:
Prostate cancer and prostatic diseases vol. 19
Availability: No items available.
|
|
95.
|
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward. [electronic resource] by
- Harshman, L C
- Drake, C G
- Haas, N B
- Manola, J
- Puligandla, M
- Signoretti, S
- Cella, D
- Gupta, R T
- Bhatt, R
- Van Allen, E
- Lara, P
- Choueiri, T K
- Kapoor, A
- Heng, D Y C
- Shuch, B
- Jewett, M
- George, D
- Michaelson, D
- Carducci, M A
- McDermott, D
- Allaf, M
Publication details: Kidney cancer (Clifton, Va.) Jul 2017
In:
Kidney cancer (Clifton, Va.) vol. 1
Availability: No items available.
|
|
96.
|
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. [electronic resource] by
- Simons, J W
- Jaffee, E M
- Weber, C E
- Levitsky, H I
- Nelson, W G
- Carducci, M A
- Lazenby, A J
- Cohen, L K
- Finn, C C
- Clift, S M
- Hauda, K M
- Beck, L A
- Leiferman, K M
- Owens, A H
- Piantadosi, S
- Dranoff, G
- Mulligan, R C
- Pardoll, D M
- Marshall, F F
Producer: 19970501
In:
Cancer research vol. 57
Availability: No items available.
|
|
97.
|
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. [electronic resource] by
- Nelson, W G
- Simons, J W
- Mikhak, B
- Chang, J F
- DeMarzo, A M
- Carducci, M A
- Kim, M
- Weber, C E
- Baccala, A A
- Goeman, M A
- Clift, S M
- Ando, D G
- Levitsky, H I
- Cohen, L K
- Sanda, M G
- Mulligan, R C
- Partin, A W
- Carter, H B
- Piantadosi, S
- Marshall, F F
Producer: 20000906
In:
Cancer chemotherapy and pharmacology vol. 46 Suppl
Availability: No items available.
|
|
98.
|
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. [electronic resource] by
- Bubley, G J
- Carducci, M
- Dahut, W
- Dawson, N
- Daliani, D
- Eisenberger, M
- Figg, W D
- Freidlin, B
- Halabi, S
- Hudes, G
- Hussain, M
- Kaplan, R
- Myers, C
- Oh, W
- Petrylak, D P
- Reed, E
- Roth, B
- Sartor, O
- Scher, H
- Simons, J
- Sinibaldi, V
- Small, E J
- Smith, M R
- Trump, D L
- Wilding, G
Producer: 20000118
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
99.
|
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. [electronic resource] by
- Simons, J W
- Mikhak, B
- Chang, J F
- DeMarzo, A M
- Carducci, M A
- Lim, M
- Weber, C E
- Baccala, A A
- Goemann, M A
- Clift, S M
- Ando, D G
- Levitsky, H I
- Cohen, L K
- Sanda, M G
- Mulligan, R C
- Partin, A W
- Carter, H B
- Piantadosi, S
- Marshall, F F
- Nelson, W G
Producer: 19991110
In:
Cancer research vol. 59
Availability: No items available.
|
|
100.
|
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. [electronic resource] by
- Armstrong, A J
- Antonarakis, E S
- Taplin, M-E
- Kelly, W K
- Beltran, H
- Fizazi, K
- Dahut, W L
- Shore, N
- Slovin, S
- George, D
- Carducci, M A
- Corn, P
- Danila, D
- Dreicer, R
- Heath, E
- Rathkopf, D
- Liu, G
- Nanus, D
- Stein, M
- Smith, M R
- Sternberg, C
- Wilding, G
- Nelson, P S
- Halabi, S
- Kantoff, P
- Clarke, N W
- Evans, C P
- Heidenreich, A
- Mottet, N
- Gleave, M
- Morris, M J
- Scher, H I
Producer: 20190311
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|